# FDA Inspection 1239659 - Zhejiang Ausun Pharmaceutical Co., Ltd. - April 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-ausun-pharmaceutical-co-ltd/0892984c-2848-4e43-852a-98101bd8d152
Source feed: FDA_Inspections

> FDA Inspection 1239659 for Zhejiang Ausun Pharmaceutical Co., Ltd. on April 26, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1239659
- Company Name: Zhejiang Ausun Pharmaceutical Co., Ltd.
- Inspection Date: 2024-04-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1068561 - 2018-05-25](https://www.keypedia.com/records/fda_inspections/zhejiang-ausun-pharmaceutical-co-ltd/110d9eb1-c273-440a-ab3b-251be2d0fa31)
- [FDA Inspection 905582 - 2014-10-31](https://www.keypedia.com/records/fda_inspections/zhejiang-ausun-pharmaceutical-co-ltd/62980d4a-6861-44d0-a6d4-d41f31c7578e)

Company: https://www.keypedia.com/companies/zhejiang-ausun-pharmaceutical-co-ltd/5c30ecf3-fdd1-4d64-833f-d28cc43b3da4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c